FY2024 EPS Estimates for Transcat, Inc. Lowered by Analyst (NASDAQ:TRNS)

Transcat, Inc. (NASDAQ:TRNS) – Analysts at HC Wainwright cut their FY2024 earnings estimates for Transcat in a research report issued to clients and investors on Tuesday, April 16th. HC Wainwright analyst S. Buck now expects that the scientific and technical instruments company will earn $1.35 per share for the year, down from their previous estimate of $1.45. HC Wainwright has a “Buy” rating and a $124.00 price objective on the stock. The consensus estimate for Transcat’s current full-year earnings is $1.36 per share. HC Wainwright also issued estimates for Transcat’s Q4 2024 earnings at $0.53 EPS.

Separately, TheStreet upgraded shares of Transcat from a “c+” rating to a “b” rating in a research note on Wednesday, January 31st.

Transcat Price Performance

Transcat stock opened at $104.71 on Wednesday. Transcat has a 52 week low of $74.89 and a 52 week high of $115.41. The company’s 50 day moving average price is $108.70 and its two-hundred day moving average price is $101.88. The stock has a market cap of $924.59 million, a P/E ratio of 80.55 and a beta of 0.59. The company has a quick ratio of 2.81, a current ratio of 3.37 and a debt-to-equity ratio of 0.01.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Monday, January 29th. The scientific and technical instruments company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. Transcat had a return on equity of 9.32% and a net margin of 4.16%. The firm had revenue of $65.17 million during the quarter, compared to analyst estimates of $63.36 million.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in TRNS. US Bancorp DE raised its stake in shares of Transcat by 137.9% during the first quarter. US Bancorp DE now owns 345 shares of the scientific and technical instruments company’s stock worth $28,000 after acquiring an additional 200 shares in the last quarter. BNP Paribas Arbitrage SA grew its holdings in shares of Transcat by 162.3% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 1,626 shares of the scientific and technical instruments company’s stock valued at $92,000 after purchasing an additional 1,006 shares during the last quarter. Barclays PLC raised its position in Transcat by 533.1% in the 4th quarter. Barclays PLC now owns 1,912 shares of the scientific and technical instruments company’s stock worth $135,000 after purchasing an additional 1,610 shares during the period. Tower Research Capital LLC TRC lifted its stake in Transcat by 345.5% in the fourth quarter. Tower Research Capital LLC TRC now owns 1,234 shares of the scientific and technical instruments company’s stock worth $135,000 after purchasing an additional 957 shares during the last quarter. Finally, Legal & General Group Plc boosted its position in Transcat by 219.9% during the fourth quarter. Legal & General Group Plc now owns 2,703 shares of the scientific and technical instruments company’s stock valued at $192,000 after buying an additional 1,858 shares during the period. Institutional investors own 98.34% of the company’s stock.

Insider Buying and Selling at Transcat

In related news, Director Charles P. Hadeed sold 700 shares of the company’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $113.00, for a total transaction of $79,100.00. Following the sale, the director now owns 22,678 shares of the company’s stock, valued at approximately $2,562,614. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Lee D. Rudow sold 2,373 shares of the company’s stock in a transaction that occurred on Saturday, March 30th. The shares were sold at an average price of $111.43, for a total value of $264,423.39. Following the transaction, the chief executive officer now directly owns 103,688 shares in the company, valued at $11,553,953.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Charles P. Hadeed sold 700 shares of Transcat stock in a transaction on Monday, February 12th. The stock was sold at an average price of $113.00, for a total transaction of $79,100.00. Following the sale, the director now directly owns 22,678 shares of the company’s stock, valued at $2,562,614. The disclosure for this sale can be found here. Insiders sold 8,073 shares of company stock valued at $900,023 in the last quarter. 4.20% of the stock is currently owned by corporate insiders.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.